Bracco Research USA Inc

Bracco Research USA Inc is a leading global healthcare group with a rich history dating back to 1927. Originally a pharmaceutical trading concern, Bracco has evolved into an independent industrial production and research facility, specializing in diagnostic imaging solutions. The company is responsible for the discovery and development of the iopamidol molecule, the first ready-to-use nonionic contrast medium. Bracco's product offerings span across various medical needs, including cardiac, vascular, abdominal, and neuroimaging. In addition to its own products, Bracco also markets diagnostic imaging resources through its subsidiaries, including ACIST Medical Systems and Volume Interactions. The company is headquartered in Princeton, N.J.